Thermo Fisher Scientific extends partnership with Symphogen to support biopharma
Thermo Fisher and Symphogen extend their collaboration using innovative and efficient workflows to improve data confidence, aiding the creation of new cancer treatments
Thermo Fisher and Symphogen extend their collaboration using innovative and efficient workflows to improve data confidence, aiding the creation of new cancer treatments
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
The 15-year agreement will leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies
By connecting a leading LongBio VC to the DeSci (decentralized science) movement, this partnership is a major milestone for the greater decentralized ecosystem
Recall does not include any metabolic deficiency nutrition formulas
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
Nearly 1 million people are living with multiple sclerosis in the United States. Spasticity is a commonly reported symptom for MS, with an estimated prevalence of spasticity of 67%
The six-layer packaging ensures that external media such as bacteria, light and air do not contaminate the liquid
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
The stability is led by healthy demand in the domestic and emerging markets
Subscribe To Our Newsletter & Stay Updated